Foxl2em1Amp
Endonuclease-mediated Allele Detail
|
|
| Symbol: |
Foxl2em1Amp |
| Name: |
forkhead box L2; endonuclease-mediated mutation 1, Alberto M Pendas |
| MGI ID: |
MGI:7427813 |
| Synonyms: |
Foxl2C134W |
| Gene: |
Foxl2 Location: Chr9:98837495-98840601 bp, + strand Genetic Position: Chr9, 51.41 cM, cytoband E4
|
| Alliance: |
Foxl2em1Amp page
|
|
| Strain of Origin: |
C57BL/6J x CBA/J
|
|
| Allele Type: |
|
Endonuclease-mediated (Humanized sequence) |
| Mutation: |
|
Single point mutation
|
| |
|
Mutation details: CRISPR/Cas9 technology generated a C to G change resulting in a cysteine to tryptophan substitution at amino acid 130 (p.C130W). This corresponds to the human p.C134W variant seen in individuals with adult-type granulosa cell tumors. An additional mutation that destroys the Protospacer Adjacent Motif (GCC to GCA) was also introduced.
(J:332589)
|
|
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Foxl2 Mutation: |
16 strains or lines available
|
|
| Original: |
J:332589 Llano E, et al., The Oncogenic FOXL2 C134W Mutation Is a Key Driver of Granulosa Cell Tumors. Cancer Res. 2023 Jan 18;83(2):239-250 |
| All: |
1 reference(s) |
|